Relationship between breakthrough cancer pain, background cancer pain and analgesic treatment - case series and review of the literature

The assessment and treatment of breakthrough cancer pain (BTcP) remain a major challenge in medicine due to its high impact on several aspects of health-related quality of life. BTcP should be carefully monitored in all cancer care settings by a multidisciplinary team to provide an appropriate and p...

Full description

Saved in:
Bibliographic Details
Main Authors: Chrysanthi Batistaki (Author), Michal Graczyk (Author), Marcin Janecki (Author), Agata Anna Lewandowska (Author), Rita Moutinho (Author), Kiriaki Vagdatli (Author)
Format: Book
Published: BioExcel Publishing Ltd, 2022-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_bf5a2449293742f983f2f83adb0a7ce2
042 |a dc 
100 1 0 |a Chrysanthi Batistaki  |e author 
700 1 0 |a Michal Graczyk  |e author 
700 1 0 |a Marcin Janecki  |e author 
700 1 0 |a Agata Anna Lewandowska  |e author 
700 1 0 |a Rita Moutinho  |e author 
700 1 0 |a Kiriaki Vagdatli  |e author 
245 0 0 |a Relationship between breakthrough cancer pain, background cancer pain and analgesic treatment - case series and review of the literature 
260 |b BioExcel Publishing Ltd,   |c 2022-12-01T00:00:00Z. 
500 |a 10.7573/dic.2022-9-4 
500 |a 1740-4398 
520 |a The assessment and treatment of breakthrough cancer pain (BTcP) remain a major challenge in medicine due to its high impact on several aspects of health-related quality of life. BTcP should be carefully monitored in all cancer care settings by a multidisciplinary team to provide an appropriate and personalized clinical approach. The aim of this paper is to provide healthcare professionals involved in cancer pain management with a review of the relevant literature on the relationship between background cancer pain and BTcP which, by definition, occurs despite adequately controlled background cancer pain. The clinical cases presented contribute to a better understanding of this issue and underline its impact in daily clinical practice. This article is part of the Management of breakthrough cancer pain Special Issue: https://www.drugsincontext.com/special_issues/management-of-breakthrough-cancer-pain 
546 |a EN 
690 |a analgesic treatment 
690 |a background cancer pain 
690 |a breakthrough cancer pain 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Drugs in Context, Vol 11, Pp 1-10 (2022) 
787 0 |n https://drugsincontext.com/relationship-between-breakthrough-cancer-pain-background-cancer-pain-and-analgesic-treatment-case-series-and-review-of-the-literature 
787 0 |n https://doaj.org/toc/1740-4398 
856 4 1 |u https://doaj.org/article/bf5a2449293742f983f2f83adb0a7ce2  |z Connect to this object online.